S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary
S&P 500   4,585.59
DOW   36,117.38
QQQ   390.43
Forward dividend yield: What it is and how to use it 
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
What are consumer staples stocks?
Healthcare sector: Overview and keys to investing
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity (Ad)
Is Amazon a blue chip stock?
How to find penny stocks to invest and trade 
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
How to invest in GTE technology: A guide 
Consumer staples vs. consumer discretionary

Integra LifeSciences Stock Price, News & Analysis (NASDAQ:IART)

$41.31
+0.38 (+0.93%)
(As of 12/7/2023 ET)
Compare
Today's Range
$40.51
$41.45
50-Day Range
$34.21
$41.51
52-Week Range
$33.44
$60.69
Volume
565,964 shs
Average Volume
623,138 shs
Market Capitalization
$3.23 billion
P/E Ratio
34.14
Dividend Yield
N/A
Price Target
$46.00

Integra LifeSciences MarketRank™ Stock Analysis

Analyst Rating
Hold
2.11 Rating Score
Upside/​Downside
11.4% Upside
$46.00 Price Target
Short Interest
Healthy
3.67% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.50
Upright™ Environmental Score
News Sentiment
0.64mentions of Integra LifeSciences in the last 14 days
Based on 10 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
9.97%
From $3.11 to $3.42 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.24 out of 5 stars

Medical Sector

310th out of 960 stocks

Surgical & Medical Instruments Industry

35th out of 75 stocks


IART stock logo

About Integra LifeSciences Stock (NASDAQ:IART)

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.

IART Stock Price History

IART Stock News Headlines

Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
INTEGRA ALERT: Bragar Eagel & Squire, P.C....
Integra Lifesciences Holdings Corp IART
See More Headlines
Receive IART Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integra LifeSciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/25/2023
Today
12/07/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/28/2024

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:IART
CUSIP
45798520
Employees
3,722
Year Founded
1989

Price Target and Rating

Average Stock Price Target
$46.00
High Stock Price Target
$60.00
Low Stock Price Target
$37.00
Potential Upside/Downside
+11.4%
Consensus Rating
Hold
Rating Score (0-4)
2.11
Research Coverage
9 Analysts

Profitability

Net Income
$180.55 million
Pretax Margin
7.55%

Debt

Sales & Book Value

Annual Sales
$1.54 billion
Cash Flow
$4.89 per share
Book Value
$21.57 per share

Miscellaneous

Free Float
75,909,000
Market Cap
$3.23 billion
Optionable
Optionable
Beta
1.18

Social Links

The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives















IART Stock Analysis - Frequently Asked Questions

Should I buy or sell Integra LifeSciences stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Integra LifeSciences in the last twelve months. There are currently 3 sell ratings, 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" IART shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in IART, but not buy additional shares or sell existing shares.
View IART analyst ratings
or view top-rated stocks.

What is Integra LifeSciences' stock price target for 2024?

9 analysts have issued 1 year price targets for Integra LifeSciences' stock. Their IART share price targets range from $37.00 to $60.00. On average, they predict the company's stock price to reach $46.00 in the next twelve months. This suggests a possible upside of 11.4% from the stock's current price.
View analysts price targets for IART
or view top-rated stocks among Wall Street analysts.

How have IART shares performed in 2023?

Integra LifeSciences' stock was trading at $56.07 at the beginning of 2023. Since then, IART stock has decreased by 26.3% and is now trading at $41.31.
View the best growth stocks for 2023 here
.

When is Integra LifeSciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 28th 2024.
View our IART earnings forecast
.

How were Integra LifeSciences' earnings last quarter?

Integra LifeSciences Holdings Co. (NASDAQ:IART) announced its quarterly earnings results on Wednesday, October, 25th. The life sciences company reported $0.76 EPS for the quarter, missing the consensus estimate of $0.78 by $0.02. The life sciences company earned $382.40 million during the quarter, compared to the consensus estimate of $387.22 million. Integra LifeSciences had a net margin of 6.54% and a trailing twelve-month return on equity of 15.28%. The company's revenue was down .7% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.86 earnings per share.

When did Integra LifeSciences' stock split?

Shares of Integra LifeSciences split on Tuesday, January 3rd 2017. The 2-1 split was announced on Thursday, December 22nd 2016. The newly issued shares were issued to shareholders after the closing bell on Wednesday, December 21st 2016. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

What guidance has Integra LifeSciences issued on next quarter's earnings?

Integra LifeSciences issued an update on its fourth quarter earnings guidance on Wednesday, October, 25th. The company provided EPS guidance of $0.89-0.93 for the period, compared to the consensus EPS estimate of $0.92. The company issued revenue guidance of $397-403 million, compared to the consensus revenue estimate of $405.49 million.

What is Peter J. Arduini's approval rating as Integra LifeSciences' CEO?

173 employees have rated Integra LifeSciences Chief Executive Officer Peter J. Arduini on Glassdoor.com. Peter J. Arduini has an approval rating of 74% among the company's employees.

What other stocks do shareholders of Integra LifeSciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Integra LifeSciences investors own include Boeing (BA), NVIDIA (NVDA), AbbVie (ABBV), Adobe (ADBE), Advanced Micro Devices (AMD), Gilead Sciences (GILD), Intel (INTC), Marvell Technology (MRVL), Alexion Pharmaceuticals (ALXN) and Abbott Laboratories (ABT).

Who are Integra LifeSciences' major shareholders?

Integra LifeSciences' stock is owned by a number of institutional and retail investors. Top institutional investors include Clearbridge Investments LLC (3.51%), Victory Capital Management Inc. (1.87%), Deerfield Management Company L.P. Series C (1.44%), AQR Capital Management LLC (0.98%), Assenagon Asset Management S.A. (0.85%) and Bank of New York Mellon Corp (0.81%). Insiders that own company stock include Eric Schwartz, Glenn Coleman, Jeffrey Mosebrook, Lisa Evoli, Michael J Mcbreen, Raymond G Murphy, Stuart Essig, Tru St Partnership, LP and Witte Jan De.
View institutional ownership trends
.

How do I buy shares of Integra LifeSciences?

Shares of IART stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

Does Integra LifeSciences have any subsidiaries?
The following companies are subsidiares of Integra LifeSciences: ACell Inc, ACell Inc., Arkis BioSciences, Arkis Biosciences Inc., Ascension Orthopedics Inc., Ascension Orthopedics Limited, BIMECO Inc., BioD LLC, BioDlogics LLC, BioRecovery LLC, CardioDyne Inc., Cathtec Incorporated, Caveangle Limited, Codman Neuro, Confluent Surgical, Confluent Surgical Inc., Derma First Aid Products Inc., Derma Sciences, Derma Sciences Canada Inc., Derma Sciences Europe Limited, Derma Sciences Inc., EndoSolutions Inc., Fiber Imaging Technologies Inc., GMS Gesellschaft für medizinische Sondentechnik mbH, ILS Financing (Ireland) Limited, ILS Financing Corporation, ILS Services Switzerland Ltd., ILS Surgical Investments LLC, INS Sweden AB, Integra Burlington MA Inc., Integra CI Inc., Integra Canada ULC, Integra Euro Holdings Inc., Integra France Holdings SAS, Integra German Holdings GmbH, Integra GmbH, Integra Japan K.K., Integra LS (Benelux) NV, Integra LS Mexico S. DE R. L. DE C.V., Integra LifeSciences (Canada) Holdings Inc., Integra LifeSciences (Ireland) Limited, Integra LifeSciences (Shanghai) Co. Ltd., Integra LifeSciences Austria GmbH, Integra LifeSciences Brazil Ltda., Integra LifeSciences Corporation, Integra LifeSciences Enterprises LLLP, Integra LifeSciences Financing (Cyprus) Limited, Integra LifeSciences Italy S.r.l., Integra LifeSciences Middle East FZ-LLC, Integra LifeSciences Production Corporation, Integra LifeSciences Sales LLC, Integra LifeSciences Services (France) SAS, Integra LifeSciences Shared Services (Ireland) Limited, Integra LifeSciences Singapore Pte. Ltd., Integra LifeSciences Spain S.L., Integra LifeSciences Switzerland Sárl, Integra Luxtec Inc., Integra ME GmbH, Integra MicroFrance SAS, Integra NeuroSciences (International) Inc., Integra NeuroSciences Holdings (UK) Limited, Integra NeuroSciences Holdings B.V., Integra NeuroSciences Implants (France) SAS, Integra NeuroSciences Limited, Integra Neurosciences, Integra Neurosciences Pty Ltd. (AUS), Integra Neurosciences Pty Ltd. (NZ), Integra Receivables LLC, Integra Sales Inc., Integra Selector LLC, Integra Switzerland Holdings Sarl, Integra York PA Inc., IsoTis NV, IsoTis T.E. Facility B.V., J. Jamner Surgical Instruments Inc., Jarit GmbH, Kinetikos Medical, Koby Ventures II L.P. dba Metasurg, LXU Healthcare Inc. - Medical Specialty Products, MedEfficiency Inc., Medtronic Xomed Instrumentation SAS, Miltex, Minnesota Scientific Inc., Nantong Derma Medical Products Co. Ltd., Newdeal Inc., Newdeal SAS, Omni-Tract, Precise Dental Holding Corp., Precise Dental Internacional S.A. de C.V., Precise Dental Products Ltd., Precision Dental International Inc., Rebound Therapeutics, Rebound Therapeutics Corporation, Spembly Cryosurgery Limited, Spembly Medical Limited, TEI Biosciences (UK) Limited, TEI Biosciences Inc., TEI Biosciences Inc., TEI Medical Inc., TGX Medical Systems, TGX Medical Systems LLC, Tarsus Medical Inc., Tarsus Medical Inc., Tekmed Instruments S.p.A, Theken Disc, Theken Spine, and Therics.
Read More
This page (NASDAQ:IART) was last updated on 12/8/2023 by MarketBeat.com Staff

My Account -